Rep. Lisa C. McClain Sells Off Shares of The Clorox Company (NYSE:CLX)

Representative Lisa C. McClain (R-Michigan) recently sold shares of The Clorox Company (NYSE:CLX). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Clorox stock on October 31st. The trade occurred in the Representative’s “CHARLES SCHWAB 401K > SCHWAB 893” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Sprouts Farmers Market (NASDAQ:SFM) on 10/31/2025.

Clorox Stock Performance

Shares of CLX stock opened at $105.78 on Tuesday. The company has a market capitalization of $12.90 billion, a price-to-earnings ratio of 16.22, a price-to-earnings-growth ratio of 0.92 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The Clorox Company has a one year low of $98.20 and a one year high of $171.37. The company’s 50-day moving average is $114.94 and its 200 day moving average is $121.97.

Clorox (NYSE:CLX) last issued its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the prior year, the firm posted $1.86 earnings per share. The business’s revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be paid a $1.24 dividend. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a yield of 4.7%. Clorox’s payout ratio is presently 77.86%.

Insider Buying and Selling at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Pierre R. Breber acquired 4,000 shares of the stock in a transaction dated Friday, November 21st. The shares were bought at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the transaction, the director owned 13,000 shares in the company, valued at approximately $1,353,690. This represents a 44.44% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.63% of the company’s stock.

Institutional Investors Weigh In On Clorox

Hedge funds and other institutional investors have recently made changes to their positions in the business. Invesco Ltd. boosted its holdings in shares of Clorox by 138.3% in the second quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock worth $389,648,000 after buying an additional 1,883,465 shares during the last quarter. Norges Bank purchased a new stake in Clorox during the second quarter valued at approximately $190,429,000. Van ECK Associates Corp raised its position in Clorox by 93.9% in the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after acquiring an additional 1,312,471 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in shares of Clorox by 218.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock worth $149,983,000 after acquiring an additional 856,873 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC bought a new stake in shares of Clorox during the 2nd quarter valued at $71,856,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analysts Set New Price Targets

Several analysts have commented on CLX shares. BNP Paribas Exane cut their target price on Clorox from $110.00 to $103.00 and set an “underperform” rating on the stock in a research note on Tuesday, November 4th. Bank of America dropped their price objective on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. JPMorgan Chase & Co. decreased their target price on Clorox from $127.00 to $120.00 and set a “neutral” rating for the company in a research report on Tuesday, November 4th. Barclays lowered their target price on shares of Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a research note on Tuesday, November 4th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 14th. One analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $125.69.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.